Altafluor
Generic name: fluorescein sodium and benoxinate hydrochloride
Dosage form: ophthalmic solution
Drug class:Ophthalmic diagnostic agents
Medically reviewed by Drugs.com. Last updated on Nov 22, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Use In Specific Populations
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
1 INDICATIONS AND USAGE
Altafluor Benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution) 0.25%/0.4% is indicated for ophthalmic procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent.
2 DOSAGE AND ADMINISTRATION
Instill 1 to 2 drops of Altafluor Benox in the eye as needed.
3 DOSAGE FORMS AND STRENGTHS:
Altafluor Benox is a yellow to orange-red ophthalmic solution containing fluorescein sodium 2.5 mg/mL (0.25%) and benoxinate hydrochloride 4 mg/mL (0.4%).
4 CONTRAINDICATIONS:
Altafluor Benox is contraindicated in patients with known hypersensitivity to any component of this product.
5 WARNINGS AND PRECAUTIONS
5.1 Corneal Toxicity
Prolonged use or abuse may lead to corneal epithelial toxicity which may manifest as epithelial defects and progress to permanent corneal opacification with accompanying visual loss.
5.2 Corneal Injury Due to Insensitivity
Patient should not touch the eye for approximately 20 minutes after using this anesthetic as accidental injuries can occur due to insensitivity of the eye.
6 ADVERSE REACTIONS
The following ocular adverse reactions are described elsewhere in the labeling:
- Corneal Toxicity [seeWarnings and Precautions (5.1)]
- Corneal Injury due to Insensitivity
